Breaking News Instant updates and real-time market news.

GOOGL

Alphabet Class A

$1,166.83

-0.61 (-0.05%)

, FB

Facebook

$203.52

-1.3 (-0.63%)

17:05
07/10/18
07/10
17:05
07/10/18
17:05

Nomura Instinet initiates coverage on Americas Internet

Nomura Instinet initiated coverage on nine names within the Americas Internet sector. The firm believes, overall, that there is "still some room for growth in digital advertising for the foreseeable future" and believes it will be led primarily by digital video and social, and primarily on mobile devices. The firm added that, as a result of slowing user growth and already high internet penetration, the growth will likely be led by pricing, rather than volume, and the consistent shift away from offline to online media. Nomura Instinet forecast the global digital advertising market "will grow at a 15% five-year CAGR through 2020 as digital ads work toward constituting half of total advertising spend," which the firm expects to occur in 2020. Nomura Instinet initiated Alphabet Class A (GOOGL), Facebook (FB), and Spotify (SPOT) with Buy ratings, and added that Alphabet and Facebook were the best positioned in this newly regulated industry. It initiated Netflix (NFLX), Snap (SNAP), Trade Desk (TTD), Criteo (CRTO), and Pandora (P) with Neutral ratings. It initiated Twitter (TWTR) with a Reduce rating, saying that while it is a "stable long-term asset that has something for everyone," the firm believes the market is pricing in "a significant advertising reacceleration that implies a shift in ad spend," while the firm expects "stability instead of a reacceleration of growth."

GOOGL

Alphabet Class A

$1,166.83

-0.61 (-0.05%)

FB

Facebook

$203.52

-1.3 (-0.63%)

SPOT

Spotify

$180.45

3.04 (1.71%)

TWTR

Twitter

$43.74

-0.39 (-0.88%)

NFLX

Netflix

$415.48

-3.5 (-0.84%)

SNAP

Snap

$13.31

-0.35 (-2.56%)

TTD

Trade Desk

$92.70

-1.86 (-1.97%)

CRTO

Criteo

$35.10

0.18 (0.52%)

P

Pandora

$7.72

-0.27 (-3.38%)

  • 12

    Jul

  • 16

    Jul

  • 17

    Jul

  • 23

    Jul

  • 25

    Jul

  • 26

    Jul

  • 27

    Jul

GOOGL Alphabet Class A
$1,166.83

-0.61 (-0.05%)

07/09/18
DADA
07/09/18
NO CHANGE
Target $8
DADA
Buy
Groupon offers 'tremendous value' in potential sale, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon following speculation by Recode over the weekend that the company is looking to sell itself. Forte recommends that investors purchase shares, stating that the market is underpricing Groupon as its "North American business has never been in better shape and its international operations are well positioned". In a bull case, the analyst contends that Groupon could be worth $12 per share if it can improve its growth rate or find a strategic buyer where a deal would value the two companies higher than the sum of their parts. Forte speculates about Priceline (PCLN), Alibaba (BABA), Google (GOOGL), and Facebook (FB) as potential acquirers for Groupon.
07/02/18
JEFF
07/02/18
NO CHANGE
JEFF
Jefferies sees rotation coming to Technology, downgrades sector rating
Jefferies equity strategist Steven DeSanctis downgraded his rating on the Technology sector to a Market Weight from Overweight. "Sentiment is too strong and we sense a rotation coming," DeSanctis tells investors in a research note. On Biotech, the analyst recommends staying selective as the sector "is nearing an all-time high weight in small growth benchmarks." On Financials, DeSanctis says that while the sector has not worked for 18 months, rising interest rates, more deal activity and cheaper valuations could get the group moving higher.
06/28/18
MSCO
06/28/18
NO CHANGE
Target $1250
MSCO
Overweight
Alphabet should be giving away Google Home, says Morgan Stanley
Morgan Stanley analyst Brian Nowak lowered his FY18 EPS estimate for Alphabet (GOOGL) by 1%, citing the impact of foreign exchange and company investments on Cloud, Hardware, and YouTube, and noted that he expects Q2 EPS to miss consensus by 1%. However, he would be a buyer on any weakness through Q2 results and raised his price target on Alphabet shares to $1,250 from $1,200 given a higher view on its long-term earnings. Nowak estimates U.S. household penetration of smart speakers will grow to about 70% by 2022, with Amazon (AMZN) having 1.3 times more Echos in use than Google Home devices. Given this view, and his expectation for voice shopping to lead to faster e-commerce adoption, Nowak argues that Alphabet should give away a Google Home Mini to every U.S. household, and possibly even everyone globally. The cost would be "only" $3.3B, and the larger personal assistant base would let Google grow its emerging voice technologies, according to Nowak, who keeps an Overweight rating on Alphabet.
07/10/18
NOMU
07/10/18
INITIATION
Target $1400
NOMU
Buy
Alphabet Class A initiated with a Buy at Nomura Instinet
Nomura initiated Alphabet Class A with a Buy and $1,400 price target.
FB Facebook
$203.52

-1.3 (-0.63%)

07/10/18
CLVD
07/10/18
INITIATION
CLVD
Buy
Facebook assumed with a Buy at Cleveland Research
Cleveland Research analyst Chandler Converse assumed Facebook with a Buy and $230 price target saying he expects continued ad spend strength in the US and Europe, sees potential upside from Instagram, and long-term opportunities in content, messaging, and ecommerce.
07/10/18
MSCO
07/10/18
NO CHANGE
Target $215
MSCO
Overweight
Morgan Stanley remains bullish on Facebook, ups price target to $215
Morgan Stanley analyst Brian Nowak said he remains bullish Facebook, stating that its scaling ad revenue is driving cash flow and earning power. He models ad revenue growth ex-forex of 45% year-over-year in Q2, including Instagram ad revenue growth of 69% year-over-year, noting that advertiser and ad agency commentary around Instagram remains notably positive. Nowak raised his FY18 and FY19 EBITDA estimates buy 1% each and increased his price target on Facebook shares to $215 from $210. He keeps an Overweight rating on the stock.
07/10/18
NOMU
07/10/18
INITIATION
Target $228
NOMU
Buy
Facebook initiated with a Buy at Nomura Instinet
Nomura initiated Facebook with a Buy and $228 price target.
SPOT Spotify
$180.45

3.04 (1.71%)

07/09/18
OPCO
07/09/18
INITIATION
OPCO
Perform
Spotify initiated with a Perform at Oppenheimer
Oppenheimer analyst Jason Helfstein started Spotify Technology with a Perform rating and no price target. The analyst calculates the stock's intrinsic value range at $160-$170 per share or 13-14 time estimated 2019 gross profit. The shares closed the trading day up $1.74 to $177.44. The analyst believes Spotify will benefit from the "secular tailwind of growing digital music streaming adoption" but questions the extent to which it can differentiate its service to maintain market share. Further, Spotify's attempts to improve gross margin by licensing music direct will likely be stymied by labels and premium placement in playlists is "expected," rather than a "paid for" service, Helfstein tells investors in a research note partially titled "A Too Familiar Tune."
07/10/18
07/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Perform at Oppenheimer. 2. CME Group (CME) initiated with a Neutral at Compass Point. 3. Weight Watchers (WTW) initiated with an Overweight at KeyBanc. 4. Fossil (FOSL) initiated with an Overweight at KeyBanc. 5. Alvarion (ALVR) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
NOMU
07/10/18
INITIATION
Target $210
NOMU
Buy
Spotify initiated with a Buy at Nomura Instinet
Nomura initiated Spotify with a Buy and $210 price target.
07/09/18
MKMP
07/09/18
NO CHANGE
Target $200
MKMP
Buy
Spotify best positioned in 'highly investable' music industry, says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $200 price target on Spotify, saying the company is "best positioned and has the most interest in advancing a healthy music industry", which has become "highly investable" as its monetization has turned. The analyst further notes that after 20 years of under-investment, the industry can start to rebuild, particularly in recruiting/promoting artists and connecting them with fans. Sanderson believes that Spotify can benefit from "large value creation opportunities" and expects the company to "significantly increase in market share" in the next 5 years.
TWTR Twitter
$43.74

-0.39 (-0.88%)

07/09/18
JPMS
07/09/18
NO CHANGE
Target $50
JPMS
Overweight
Twitter selloff overdone after WaPo story on fake accounts, says JPMorgan
JPMorgan analyst Doug Anmuth attributes today's weakness in Twitter shares to a Washington Post article regarding the company stepping up its efforts to eliminate fake accounts, but he thinks the selloff has been overdone and presents a buying opportunity. He believes there is confusion around the article's contention that 70M accounts were suspended in May and June, contending that the correlation to the company's reported metrics is misunderstood. Anmuth, who continues to model MAU net additions of 2M for Q2, keeps an Overweight rating and $50 price target on Twitter shares.
07/10/18
CLVD
07/10/18
INITIATION
Target $46
CLVD
Neutral
Twitter assumed with a Neutral at Cleveland Research
Cleveland Research analyst Chandler Converse reinstated Twitter with a Neutral and $46 price target saying he is modeling CY19 above consensus on improved ad spend trends and CY19 slightly below due to concerns regarding long-term competitiveness in streaming/content.
07/10/18
NOMU
07/10/18
INITIATION
Target $31
NOMU
Reduce
Twitter initiated with a Reduce at Nomura Instinet
Nomura initiated Twitter with a Reduce and $31 price target.
07/10/18
07/10/18
INITIATION
Target $31

Reduce
Nomura Instinet starts Twitter with Reduce rating, $31 price target
As previously reported, Nomura Instinet initiated Twitter with a Reduce rating and $31 price target, stating that they view it as a unique platform, but also believe the market is pricing in a significant advertising reacceleration that implies a shift in ad spending. The firm does not expect a reacceleration of growth, but rather stability.
NFLX Netflix
$415.48

-3.5 (-0.84%)

07/09/18
IMPC
07/09/18
NO CHANGE
Target $503
IMPC
Outperform
Netflix expected to add 6.11M subscribers in Q2 at Imperial Capital
Imperial Capital analyst David Miller expects Netflix to report Q2 net subscriber additions of 6.11M, with the breakdown being 1.22M net U.S. additions, 5.05M net International additions, and the loss of 160,000 DVD-only members. The analyst believes Netflix will end Q2 with a total of 131.3M streaming subscribers within an addressable market of 2.9B high speed Internet households. He also thinks the company should be a "meaningful rise" in average selling price in the quarter. Miller keeps an Outperform rating on Netflix with a $503 price target into next week's earnings release.
07/09/18
LEHM
07/09/18
NO CHANGE
Target $450
LEHM
Overweight
Netflix price target raised to $450 from $370 at Barclays
Barclays analyst Kannan Venkateshwar raised his price target for Netflix to $450 saying he remains positive on the stock despite the 107% rally year-to-date. On a per subscriber basis, Netflix's valuation is not too far off from legacy media businesses, which are growing "significantly slower," Venkateshwar tells investors in a research note titled "What are the key risks to the story?" Further, Netflix "appears even cheap relative to names such as Spotify (SPOT), the analyst contends. His new price target reflects higher subscriber and revenue estimates. Venkateshwar keeps an Overweight rating on Netflix shares.
07/10/18
NOMU
07/10/18
INITIATION
Target $370
NOMU
Neutral
Netflix initiated with a Neutral at Nomura Instinet
Nomura initiated Netflix with a Neutral and $370 price target.
07/10/18
FBCO
07/10/18
INITIATION
Target $500
FBCO
Outperform
Netflix initiated with an Outperform at Credit Suisse
Credit Suisse analyst Doug Mitchelson initiated Netflix with an Overweight and $500 price target citing a strong content slate, increasing subs, and confidence in the market opportunity size.
SNAP Snap
$13.31

-0.35 (-2.56%)

06/06/18
DBAB
06/06/18
NO CHANGE
DBAB
Hold
Audience reach data show improving trends at Snap, says Deutsche Bank
Audience reach data show improving trends at Snap (SNAP) and stability at Facebook (FB) despite the General Data Protection Regulation rollout in Europe, Deutsche Bank analysts Lloyd Walmsley and Kunal Madhukar tells investors in a research note. The analysts "feel better" about Snap daily active user growth, and the shares, after looking at the latest trends in the Snapchat self-serve ad platform data. They reiterate a Buy rating on Facebook and Hold rating on Snap. On the latter, the analysts cite their below consensus estimates and the stock's "lack valuation support" for staying neutral on Snap.
06/19/18
COWN
06/19/18
NO CHANGE
Target $9
COWN
Underperform
Snap survey shows usage declining, says Cowen
Cowen analyst John Blackledge said his survey of Snap users shows usage is declining on both a monthly and year-over-year time period. The analyst trimmed his estimates and lowered his revenue/EBITDA forecasts following the survey. Blackledge reiterated his Underperform rating and lowered his price target to $9 from $10 on Snap shares.
06/20/18
NEED
06/20/18
NO CHANGE
NEED
Underperform
Snap Q2 revenue forecast reduced at Needham on lower DAU view
Needham analyst Laura Martin lowered her Q2 revenue forecasts on Snap by 15%, saying her channel checks suggest that the Daily Active User count will fall by 3M subscriptions in Q2 to 188M, which is also 6% below her prior estimate. The analyst keeps her Underperform rating, adding that the checks also anticipate a "dramatic slowdown in spending" by brands as a result of the major advertising events like the Grammys, Super Bowl, and NCAA finals not being repeated in Q1. Although Martin raises her Snap EPS forecast to ($1.15) from ($1.22), she attributes that to aggressive cost cutting, noting that her negative view on the company will persist until she sees some positive Daily Active User momentum.
07/05/18
BTIG
07/05/18
NO CHANGE
Target $275
BTIG
Buy
Facebook price target raised to $275 from $175 at BTIG
BTIG analyst Richard Greenfield raised his price target on Facebook (FB) to $275 and kept his Buy rating, saying the company's Instagram business is helping to grow its Mobile Time Spent operating metric. The analyst notes that Instagram now has over 1B users pay day with over 400M stories, calling that growth to the size twice as large as Snapchat (SNAP) "stunning". The analyst also states that consumers "simply could not care less" about the company's privacy practices over the past several years in spite of the regulatory scrutiny in that area across multiple countries. Greenfield contends that Facebook's personal content shift "has notably improved the quality" of the core experience on its platform, positioning the company as a "must-have utility to all demographics."
TTD Trade Desk
$92.70

-1.86 (-1.97%)

07/09/18
SBSH
07/09/18
NO CHANGE
Target $118
SBSH
Buy
Trade Desk price target raised to $118 from $94 at Citi
Citi analyst Mark May raised his price target for Trade Deskto $118 and keeps a Buy rating on the shares after taking over coverage of the name. The analyst believes the company has an opportunity to expand globally, to capture new channels like connected TV, and to increase its share of wallet with existing customers. He forecasts 35%-40% EBITDA growth in 2018 and 2019 and believes the stock can trade to $118 with continued execution.
07/09/18
PIVT
07/09/18
INITIATION
Target $58
PIVT
Sell
Trade Desk initiated with a Sell at Pivotal Research
Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating.
07/09/18
07/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GAMESTOP STARTED WITH A BUY: Jefferies analyst Stephanie Wissink started GameStop (GME) with a Buy rating and $18 price target. Her contrarian view on the stock is that under potential new leadership with a well defined vision and execution plan, the stock's valuation, which she feels is "overlooked and overly discounted," could improve. GameStop is higher by 2.5% in midday trading. PIPER SEES CISCO LOSING SECURITY SHARE TO PALO ALTO: Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's seen in past calendar quarters for Cisco Systems (CSCO). Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst said, although the former remains his top networking pick. He kept an Overweight rating on Cisco shares, which were down almost 1% in midday trading. JEFFERIES DOWNGRADES P&G: Jefferies analyst Kevin Grundy downgraded Procter & Gamble (PG) to Hold from Buy and lowered his price target for the shares to $79 from $83. Slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower, Grundy told investors in a research note titled "Tide Unlikely to Turn: Downgrade to Hold as Bull Thesis Wanes." Grundy said he preferred shares of Church & Dwight (CHD) and Energizer (ENR) for exposure to the Home and Personal Care space. TRADE DESK STARTED WITH A SELL: Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating. WELLS FARGO DOWNGRADES TWO THEME PARKS: Wells Fargo analyst Timothy Conder downgraded both SeaWorld (SEAS) and Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns, and weather impact, despite ongoing favorable consumer fundamentals and the key Q3 just starting. SeaWorld is trading down 1.3%, while Six Flags is down 1.7% at midday.
07/10/18
NOMU
07/10/18
INITIATION
Target $87
NOMU
Neutral
Trade Desk initiated with a Neutral at Nomura Instinet
Nomura initiated Trade Desk with a Neutral and $87 price target.
CRTO Criteo
$35.10

0.18 (0.52%)

07/10/18
NOMU
07/10/18
INITIATION
Target $34
NOMU
Neutral
Criteo initiated with a Neutral at Nomura Instinet
Nomura initiated Criteo with a Neutral and $34 price target.
07/09/18
PIVT
07/09/18
INITIATION
Target $48
PIVT
Buy
Criteo initiated with a Buy at Pivotal Research
Pivotal Research analyst Brian Wieser initiated Criteo (CRTO) with a Buy rating and $48 price target, citing his belief that the company will resume high single-digit growth in the mid-term and can improve its margins.
P Pandora
$7.72

-0.27 (-3.38%)

07/10/18
NOMU
07/10/18
INITIATION
Target $8
NOMU
Neutral
Pandora initiated with a Neutral at Nomura Instinet
Nomura initiated Pandora with a Neutral and $8 price target.
07/03/18
MSCO
07/03/18
NO CHANGE
Target $8
MSCO
Equal Weight
Despite good steps, too early to declare victory at Pandora, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said Pandora management is taking clear steps in the right direction and pushing out much of its 2020 debt maturity has helped reduce downside risk, but he thinks it is still too early to declare victory. The analyst, who thinks the path to ad revenue growth and sustained free cash flow is still unclear, raised his price target on Pandora shares to $8 from $6 but keeps an Equal Weight rating on the stock.
05/10/18
ADAM
05/10/18
NO CHANGE
Target $10
ADAM
Buy
Pandora management meetings increase confidence at Canaccord
Canaccord analyst Maria Ripps met with Pandora management and came away with increased confidence. The analyst said AdsWizz should support continued ad RPM construction, Premium Access and other initiatives should help the listener base return to growth, and she sees an opportunity for margin savings with the upcoming licensing talks with major labels. Ripp reiterated her Buy rating and raised her price target to $10 from $8 on Pandora shares.
05/07/18
BMOC
05/07/18
NO CHANGE
Target $9
BMOC
Outperform
Pandora price target raised to $9 from $7 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Pandora to $9 and kept his Outperform rating, saying that the investment thesis attached to his upgrade in November is playing out. The analyst notes that the acquisition of AdsWill should accelerate the monetization road map by as much as two years. Salmon also cites the rate of user decline slowing in the most recent quarter while its Premium Access offering requiring users to watch a 15-second video ad in exchange for an ad-free session is meeting with success.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$319.85

-10.4 (-3.15%)

14:57
10/20/18
10/20
14:57
10/20/18
14:57
Conference/Events
Biogen to host conference call »

Chief Medical Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

14:13
10/20/18
10/20
14:13
10/20/18
14:13
Conference/Events
Selecta Biosciences to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TROV

Trovagene

$1.12

-0.03 (-2.61%)

14:11
10/20/18
10/20
14:11
10/20/18
14:11
Conference/Events
Trovagene to host conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLS

Sellas Life Sciences

$1.56

-0.24 (-13.33%)

13:54
10/20/18
10/20
13:54
10/20/18
13:54
Conference/Events
Sellas Life Sciences to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 07

    Nov

NVS

Novartis

$87.19

0.95 (1.10%)

13:50
10/20/18
10/20
13:50
10/20/18
13:50
Conference/Events
Novartis to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

UA

Under Armour

$16.79

-0.365 (-2.13%)

, UAA

Under Armour

$18.20

-0.42 (-2.26%)

12:43
10/20/18
10/20
12:43
10/20/18
12:43
Periodicals
Under Armour stock could triple, Barron's says »

Under Armour has had a…

UA

Under Armour

$16.79

-0.365 (-2.13%)

UAA

Under Armour

$18.20

-0.42 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 30

    Oct

  • 27

    Nov

  • 03

    Mar

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

, CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

12:37
10/20/18
10/20
12:37
10/20/18
12:37
Periodicals
Constellation Brands changing CEOs, not marijuana strategy, Barron's says »

Constellation Brands…

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 14

    Nov

CFG

Citizens Financial

$36.36

1.44 (4.12%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:33
10/20/18
10/20
12:33
10/20/18
12:33
Periodicals
Citizens Financial stock worth buying, Barron's says »

Citizens Financial (CFG)…

CFG

Citizens Financial

$36.36

1.44 (4.12%)

AAPL

Apple

$219.28

3.3 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.95

-1 (-0.65%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:26
10/20/18
10/20
12:26
10/20/18
12:26
Periodicals
Netflix emerged as winner in new way to rank big tech stocks risk, Barron's says »

A year ago,…

FB

Facebook

$153.95

-1 (-0.65%)

AAPL

Apple

$219.28

3.3 (1.53%)

AMZN

Amazon.com

$1,763.91

-7.54 (-0.43%)

NFLX

Netflix

$332.69

-14.02 (-4.04%)

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

DIS

Disney

$118.81

2.55 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 03

    Mar

BABA

Alibaba

$142.90

1.1 (0.78%)

, TCEHY

Tencent

$0.00

(0.00%)

12:17
10/20/18
10/20
12:17
10/20/18
12:17
Periodicals
Chinese internet giants down, not out, Barron's says »

Alibaba (BABA), Tencent…

BABA

Alibaba

$142.90

1.1 (0.78%)

TCEHY

Tencent

$0.00

(0.00%)

BIDU

Baidu

$191.93

0.1 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 02

    Nov

BLK

BlackRock

$401.61

1.74 (0.44%)

, IVZ

Invesco

$22.00

0.74 (3.48%)

12:13
10/20/18
10/20
12:13
10/20/18
12:13
Periodicals
Fund companies sued by own employees over pricey 401k plans, Barron's says »

BlackRock (BLK),…

BLK

BlackRock

$401.61

1.74 (0.44%)

IVZ

Invesco

$22.00

0.74 (3.48%)

TROW

T. Rowe Price

$100.13

0.31 (0.31%)

SCHW

Charles Schwab

$46.81

0.11 (0.24%)

MTB

M&T Bank

$162.72

2.09 (1.30%)

MS

Morgan Stanley

$46.43

0.4 (0.87%)

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 26

    Feb

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

, BLK

BlackRock

$401.61

1.74 (0.44%)

12:04
10/20/18
10/20
12:04
10/20/18
12:04
Periodicals
Khashoggi case puts financial ties to Saudis under strain, Barron's says »

The suspected killing of…

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

BLK

BlackRock

$401.61

1.74 (0.44%)

BX

Blackstone

$34.66

-0.61 (-1.73%)

AMC

AMC Entertainment

$19.81

0.18 (0.92%)

IMAX

Imax

$22.45

-0.11 (-0.49%)

SIX

Six Flags

$66.40

-1.16 (-1.72%)

WWE

WWE

$82.02

-1.49 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 14

    Nov

  • 26

    Feb

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

A

Agilent

$64.47

-1.28 (-1.95%)

, AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
American Society of Human Genetics to hold a conference »

ASHG Conference 2018 will…

A

Agilent

$64.47

-1.28 (-1.95%)

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

BMRN

BioMarin

$103.31

-0.52 (-0.50%)

BIO

Bio-Rad

$280.96

-3.23 (-1.14%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

ILMN

Illumina

$313.31

-7.98 (-2.48%)

FLDM

Fluidigm

$7.49

-0.45 (-5.67%)

HZNP

Horizon Pharma

$19.07

-0.01 (-0.05%)

NVTA

Invitae

$12.86

-0.23 (-1.76%)

NSTG

NanoString

$15.18

-0.41 (-2.63%)

QGEN

Qiagen

$35.91

0.455 (1.28%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

RTRX

Retrophin

$25.34

0.24 (0.96%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ARQL

ArQule

$4.33

-0.38 (-8.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 27

    Nov

  • 28

    Nov

  • 24

    Dec

  • 18

    Feb

  • 03

    Mar

CLBR

Caliburn International

$0.00

(0.00%)

18:27
10/19/18
10/19
18:27
10/19/18
18:27
Syndicate
Caliburn International files registration statement for proposed IPO »

Caliburn International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

18:10
10/19/18
10/19
18:10
10/19/18
18:10
General news
Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$99.62

2.61 (2.69%)

18:02
10/19/18
10/19
18:02
10/19/18
18:02
Hot Stocks
Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe »

Celanese announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

REGN

Regeneron

$389.94

-5.45 (-1.38%)

, SNY

Sanofi

$44.57

0.12 (0.27%)

17:57
10/19/18
10/19
17:57
10/19/18
17:57
Hot Stocks
Regeneron, Sanofi: FDA approves asthma indication for Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$389.94

-5.45 (-1.38%)

SNY

Sanofi

$44.57

0.12 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

, XLU

Utilities SPDR

$54.57

0.82 (1.53%)

17:55
10/19/18
10/19
17:55
10/19/18
17:55
General news
Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound »

S&P500 SECTORS: …

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

IYR

DJ US Real Estate Index Fund

$77.83

0.63 (0.82%)

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

XLF

Financial Select Sector

$26.66

0.08 (0.30%)

XLV

Health Care Select Sector SPDR

$91.48

-0.93 (-1.01%)

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

XLI

Industrial Select Sector SPDR

$73.17

-0.31 (-0.42%)

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

SLV

iShares Silver Trust

$13.74

0.05 (0.37%)

USO

United States Oil Fund

$14.72

0.155 (1.06%)

UNG

United States Natural Gas Fund

$26.81

0.19 (0.71%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.90

0.04 (0.05%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.69

-0.15 (-0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$113.73

-0.24 (-0.21%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.12

-0.12 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$82.95

-0.035 (-0.04%)

IWD

iShares Russell 1000 Value

$122.17

0.08 (0.07%)

IWF

iShares Russell 1000 Growth

$145.19

-0.5 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSW

International Seaways

$21.51

0.41 (1.94%)

17:53
10/19/18
10/19
17:53
10/19/18
17:53
Syndicate
Breaking Syndicate news story on International Seaways »

International Seaways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$15.49

0.08 (0.52%)

17:48
10/19/18
10/19
17:48
10/19/18
17:48
Hot Stocks
Monmouth Real Estate acquires industrial building in New Jersey for $85.25M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:38
10/19/18
10/19
17:38
10/19/18
17:38
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:36
10/19/18
10/19
17:36
10/19/18
17:36
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

, LMT

Lockheed Martin

$328.22

0.21 (0.06%)

17:33
10/19/18
10/19
17:33
10/19/18
17:33
Periodicals
Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports »

President Donald Trump…

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

LMT

Lockheed Martin

$328.22

0.21 (0.06%)

BA

Boeing

$356.28

-3 (-0.84%)

GD

General Dynamics

$190.43

-0.76 (-0.40%)

BAESY

BAE Systems

$0.00

(0.00%)

HON

Honeywell

$153.49

-1.73 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.